Finance

Beta
Lists
CVKD:NASDAQ
Cadrenal Therapeutics Inc
$4.96
-0.80%
(-0.040) 1D
May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CVKD...
Open
$5.00
High
$5.19
Low
$4.91
Mkt. cap
14.23M
Avg. vol.
67.58K
Volume
28.02K
52-wk high
$15.99
52-wk low
$4.21
EPS
-$5.65
Beta
1.81
Shares outstanding
2.87M
No. of employees
5
Open
$5.00
High
$5.19
Low
$4.91
Mkt. cap
14.23M
Avg. vol.
67.58K
Volume
28.02K
52-wk high
$15.99
52-wk low
$4.21
EPS
-$5.65
Beta
1.81
Shares outstanding
2.87M
No. of employees
5
News stories
From sources across the web
About Cadrenal Therapeutics Inc
CEO-
Employees5
Founded2022
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.08M
688.46K
666.32K
771.51K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.66M
2.04M
2.40M
1.74M
Operating expense
3.73M
2.73M
3.07M
2.51M
Total operating expenses
3.73M
2.73M
3.07M
2.51M
Operating income
-3.73M
-2.73M
-3.07M
-2.51M
Other non operating income
-
-
-
-
EBT including unusual items
-3.67M
-2.69M
-3.04M
-2.50M
EBT excluding unusual items
-3.67M
-2.69M
-3.04M
-2.50M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.67M
-2.69M
-3.04M
-2.50M
Net profit margin
-
-
-
-
Earnings per share
-1.87
-1.31
-1.41
-1.04
Interest and investment income
67.00K
48.10K
26.12K
17.84K
Interest expense
-
-
-
-
Net interest expenses
67.00K
48.10K
26.12K
17.84K
Depreciation and amortization charges
401.00
401.00
555.00
555.00
EBITDA
-3.73M
-2.73M
-3.06M
-2.51M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more